Anticholinergics May Lead to the Development of Dementia Later in Life - Read by Christos Sierros

NEW YORK - EntSun -- A recent University of Nottingham study involving 58,769 participants that had been diagnosed with dementia, and being 55 years or older, discovered that treatment with potent anticholinergics on a daily basis for 3 years increased the dementia risk from 6% to 49%.

This relationship between daily treatment with potent anticholinergics and dementia risk was found to be even stronger for participants who started treatment before the age of 80, and as well as participants with the specific diagnosis of vascular dementia.

About Anticholinergics

Anticholinergics interfere with the function of neurotransmitter acetylcholine in the peripheral & central nervous systems. They selectively prevent the  neurotransmitter acetylcholine from interacting with its receptor on nerve cells. .

More on EntSun News

• The Texas Tenor Jason Davis Sr. Submits "Where Shadows Fall" for Grammy® Consideration in Best Melodic Rap Performance Category
• NJT's Second Annual NJTea: A Sneak Peek at the 2026 Season
• "Hollywood Actor Jobs" is the Title of an Employment Workshop and Micro Film Documentary
• Timber Creek Speedway Launches Exclusive Membership Program for Diecast Racing Fans
• Pioneer Spirit of Discovery Flourishes in Destination: Scientology, Sacramento

Popular Anticholinergics:

Amitriptyline
Atropine
Benztropine
Chlorpheniramine
Chlorpromazine
Clomipramine
Clozapine
Cyclobenzaprine
Cyproheptadine
Desipramine
Dexchlorpheniramine
Dicyclomine
Diphenhydramine
Doxepin
Fesoterodine
Hydroxyzine
Hyoscyamine
Imipramine
Meclizine
Nortriptyline
Olanzapine
Orphenadrine
Oxybutynin
Paroxetine
Perphenazine
Prochlorperazine
Promethazine
Protriptyline
Pseudoephedrine HCl
Scopolamine
Thioridazine
Tolterodine
Trifluoperazine
Trimipramine
Triprolidine HCl

Read by Christos Sierros (https://www.pinterest.com/ChristosSierros)